Every Form 4 that Pasqal Holding SA (PSQL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PSQL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PSQL filings page.
Pasqal Holding SA (PSQL) reported that director-associated entity Bpifrance Investissement S.A.S., through its managed funds, entered into several equity-linked positions on August 27, 2026. FPS Bpifrance Innovation I, Compartiment B Large Venture 2 purchased Senior Unsecured Convertible Bonds initially convertible into 1,041,666 ordinary shares at a conversion price of $12.00 per share with no maturity date and anti-dilution adjustments. In connection with this bond purchase, the same fund received 1,302,083 ordinary share warrants exercisable at $12.00 per share until August 27, 2031. In addition, in the Business Combination that created Pasqal Holding SA, FPS Fonds Innovation Defense and the same Bpifrance innovation fund were allocated 15,936,582 and 6,200,510 ordinary shares, respectively. No Rule 10b5-1 trading plan is indicated.
Pasqal Holding SA (PSQL) director Andrew Gundlach reported acquisitions of Ordinary Shares and warrants in connection with the closing of the Business Combination between Bleichroeder Acquisition Corp. II and Pasqal. On August 27, 2026, sponsor entities made pro rata, no‑consideration distributions of their Pasqal Ordinary Shares and warrants to members, including Mr. Gundlach and The ASG 2019 Irrevocable Trust. Following these restructuring transactions, he holds Ordinary Shares and related warrants both directly and indirectly through the trust, with the warrants exercisable at €11.50 per share starting September 26, 2026 and expiring August 27, 2031. The filing states these distributions and acquisitions were exempt under Rule 16a‑13, and Mr. Gundlach disclaims beneficial ownership of securities held by the trust except to the extent of any pecuniary interest.
Pasqal Holding SA (PSQL) reports that director Michel Combes, through an entity associated with him, acquired indirect beneficial interests in Ordinary Shares and warrants as part of a corporate restructuring tied to Pasqal’s business combination with Bleichroeder Acquisition Corp. II. On August 27, 2026, Bleichroeder Sponsor 2 LLC distributed all of its Pasqal Ordinary Shares and warrants pro rata to its members for no consideration, followed by a similar pro rata distribution by Bleichroeder Management 2 LLC to its own members. Securities reported on this Form 4 were distributed to MC Advisory L.L.C-FZ, an entity formed in Dubai of which Combes is manager; the securities are held by MC Advisory, and Combes may be deemed to beneficially own them but disclaims beneficial ownership except to the extent of any pecuniary interest.
The filing records MC Advisory’s receipt of 2,511,667 Ordinary Shares and 1,500,000 warrants (each warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share, exercisable 30 days after completion of the business combination and expiring five years after completion). The transactions are classified as exempt, “other” acquisitions under Rule 16a-13 and did not involve cash consideration or open-market trading, and no Rule 10b5-1 trading plan is reported.
Pasqal Holding SA (PSQL) reported that Chief Executive Officer and director Wasiq Mahmood Bokhari received a grant of 665,507 Founder Share Subscription warrants ("BSPCEs") on August 27, 2026, each exercisable into ordinary shares at an exercise price of EUR 50 and expiring on July 31, 2046. These BSPCEs, which relate to 15,131,063 underlying ordinary shares, were received in connection with the business combination involving Bleichroeder Acquisition Corp. II and Legacy Pasqal. As of this filing, 260,611 BSPCEs have vested and are exercisable for 5,925,289 ordinary shares, with the remainder vesting in specified equal monthly installments through July 1, 2029. No Rule 10b5‑1 trading plan is reported for this award.
Pasqal Holding SA (PSQL) reported that director and ten percent owner Georges-Olivier Reymond acquired equity interests in connection with the closing of a business combination involving Bleichroeder Acquisition Corp. II and Pasqal Holding SAS. On August 27, 2026, he received 22,185,680 ordinary shares, reflecting an automatic conversion of ordinary shares of Legacy Pasqal into newly issued ordinary shares of Pasqal Holding SA based on an exchange ratio of 22.7361449900136.
On the same date, he was granted 8,000 Founder Share Subscription Warrants ("BSPCEs"), representing rights to acquire 181,889 ordinary shares, with an exercise price of EUR 50 per share and an expiration date of July 29, 2046. As of the filing date, 2,000 BSPCEs have vested and are exercisable for 45,472 ordinary shares, and the remaining BSPCEs vest in three equal annual installments starting March 15, 2027. No Rule 10b5-1 trading plan is reported for these transactions.
Pasqal Holding SA (PSQL) reported that Chief Technology Officer Loic Antoine Henriet acquired equity interests in connection with the completion of Pasqal’s business combination with Bleichroeder Acquisition Corp. II. The reporting reflects both ordinary shares and founder share subscription warrants (BSPCEs) assumed and converted under the Business Combination Agreement’s exchange mechanics.
Henriet was granted or acquired 1,034,244 Ordinary Shares of Pasqal, which represent Legacy Pasqal ordinary shares previously held directly by him that were automatically converted into newly issued Pasqal ordinary shares using an Exchange Ratio of 22.7361449900136. He also holds 332,753 BSPCEs, which are founder share subscription warrants assumed by Pasqal. These BSPCEs carry an exercise price of EUR 50 and are exercisable for up to 7,565,520 Ordinary Shares of Pasqal when fully vested.
As of the reporting date, 129,055 BSPCEs have fully vested and are exercisable for 2,934,213 Ordinary Shares. The remaining BSPCEs vest in equal monthly installments in three tranches: (i) 1,946 BSPCEs from September 1, 2026 to July 1, 2028, (ii) 1,442 BSPCEs from September 1, 2026 to January 1, 2029, and (iii) 3,544 BSPCEs from September 1, 2026 to July 1, 2029.
Pasqal Holding SA (PSQL) reported that director Alain Jean Aspect received 973,107 ordinary shares on August 27, 2026 as a grant/award acquisition. These shares represent his previously held ordinary shares of Pasqal Holding SAS, which were automatically converted into Pasqal Holding SA ordinary shares under the companies' Business Combination Agreement.